Amgen Inc. (
) will begin trading ex-dividend on May 14, 2013. A cash dividend
payment of $0.47 per share is scheduled to be paid on June 07,
2013. Shareholders who purchased AMGN stock prior to the
ex-dividend date are eligible for the cash dividend payment. This
represents an 30.56% increase over the same period a year ago. At
the current stock price of $106.72, the dividend yield is
The previous trading day's last sale of AMGN was $106.72,
representing a -7.16% decrease from the 52 week high of $114.95 and
a 57.85% increase over the 52 week low of $67.61.
AMGN is a part of the Health Care sector, which includes
companies such as Gilead Sciences, Inc. (
) and Biogen Idec Inc. (
). AMGN's current earnings per share, an indicator of a company's
profitability, is $5.91. Zacks Investment Research reports AMGN's
forecasted earnings growth in 2013 as 11.51%, compared to an
industry average of 7.6%.
For more information on the declaration, record and payment
dates, visit the
Interested in gaining exposure to AMGN through an Exchange
Traded Fund [ETF]?
The following ETF(s) have AMGN as a top-10 holding:
- iShares NASDAQ Biotechnology Index Fund (
- First Trust Amex Biotechnology Index Fund (
- PowerShares Dynamic Biotech &Genome (
- PowerShares Dynamic Pharmaceuticals (
- Select Sector SPDR Fund - Health Care (
The top-performing ETF of this group is IBB with an increase of
30.39% over the last 100 days. It also has the highest percent
weighting of AMGN at 8.26%.